EPR21-034: Epidemiology of Diffuse Large B Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL) Patients by Line of Therapy in the United States (US) and Europe (EU)

Authors: Wenzhen Ge PhD 1 , Jon E. Arnason MD 2 , Ruben G.W. Quek PhD 1 , Katie Keeven MA 3 , Knar Nersesyan MA, MS 3 and Gena Kanas MPH, PhD 3
View More View Less
  • 1 Regeneron Pharmaceuticals Inc., Tarrytown, NY
  • 2 Beth Israel Deaconess Medical Center, Boston, MA
  • 3 Kantar - Health Division, New York, NY
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7742
Restricted access

All currencies in US Dollar

PayPal Logo

Corresponding Author: Gena Kanas, MPH, PhD
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Page Numbers:
EPR21-034
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 106 106 56
PDF Downloads 174 174 63
EPUB Downloads 0 0 0